Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Fujisawa and Solvay sign marketing agreement for antidepressant

May 27, 1997

Promising data from pivotal trials of Actiq reported at ASCO

May 26, 1997

Xanomeline improves cognitive function and behavior in AD

May 26, 1997

Oral Kytril as effective as i.v. ondansetron for emesis

May 26, 1997

AMPA receptor antagonist YM-90K for acute ischemic stroke

May 26, 1997

Pyrimidine derivatives from Roche for psychotic disorders

May 26, 1997

5-HT reuptake inhibitors disclosed by NeuroSearch

May 26, 1997

MAO-A and/or MAO-B inhibitors described by Synthelabo

May 26, 1997

EAA antagonists reported by Pharmacia & Upjohn

May 26, 1997

FUB-181: Potent and selective H3 antagonist

May 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...